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coronary sinus. Table 1 summarizes the mean anatomical measurements achieved from
the major veins of 18 human hearts. The veins are labeled as follows: Posterior
Interventricular Vein (PIV), Posterior Vein (PV), Postero-Lateral Vein (PLV), Lateral
Vein (LV), Antero-Lateral Vein (ALV), and Anterior Interventricular Vein (AIV).
Standard deviation, maximum, and minimum parameters were also taken.
Table 1: Mean anatomical parameters for 18 human cardiac venous systems
Conclusion: This novel database of cardiac venous anatomical parameters will allow
one to better visualize and understand the degree of anatomical variability that exists
between human hearts. We will continue to build this data set, which should be of great
value for both device designers and those clinically implanting cardiac devices.
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TCT-621
Long-term (5 years) Serial in vivo Evaluation of Chronic Stent Recoil after
Drug-Elutig Stent Implantation: Does it exits?
Carlos Adolfo Collet, Jose R Costa, Alexandre Abizaid, Fausto Feres, Juan S Munoz,
Ricardo Costa, Daniel Chamie, Dimitry Siqueira, Amanda Sousa, Rodolfo Staico,
Jose E Sousa
Dante Pazzanese Institute Of Cardiology, Sao Paulo, Brazil
Background: Radial expansion and scaffold properties of stainless steel stents
improved acute and mid-term outcomes of coronary angioplasty. However, late stent
recoil has been proposed as one of the possible mechanisms of in-stent restenosis. We
sought to investigate the temporal course of stent expansion using serial intravascular
ultrasound (IVUS) after stainless steel drug-eluting stent (DES) implantation.
Methods: Twenty-two patients with single de novo coronary lesions were treated with
DES with stainless steel platform (10 Cypher and 12 Biomatrix) and underwent
intravascular ultrasound at post-procedure, 9-month and 5 years after implantation. We
only included patients with at least three serial IVUS acquisitions (post procedure, mid
and very long-term). The primary endpoint was the comparison of stent volume and
stent volume index between index procedure, mid and very long-term follow-up.
Results: The mean age was 59 years, with 28% of diabetes mellitus. Stable coronary
syndrome was the initial clinical indication for the majority of the cases (88%). Stent
volume and stent volume index (SVI) were not significantly different between post-
procedure and very-long term follow-up (stent volume 140.6 ± 39.1 mm3 vs. 139.9 ±
32.7 mm3, p=0.88 and SVI 7.7 ± 1.5 mm3/mm vs. 7.8 ± 1.6 mm3/mm, p=0.77). Vessel
volume index also did not significantly changed between post-procedure and long-
term follow-up (16.4 ± 4.7 mm3/mm vs. 15.1 ± 3.6 mm3/mm, p=0.28) with a low
5-year neointinal hyperplasia percent volume of obstruction (4.8%). Regarding
incomplete stent apposition (ISA), 2 cases were observed at the index procedure and
persisted until the last evaluation. There were no cases of acquired ISA.
Conclusion: The present serial IVUS assessment represents the longest serial
evaluation of late stent expansion. There was no evidence of in vivo chronic stent recoil
after stainless steel drug-eluting stent implantation.
TCT-622
The Clinical Impact of Intravascular Ultrasound in Patients Undergoing
Implantation of Drug-eluting Stents in the Left Main
Abdi Jama, Federico Conrotto, Ryan Lennon, Amir Lerman
Cardiology, Mayo Clinic, Rochester, MN
Background: The clinical utility of intravascular ultrasound during left main stenting
with drug-eluting stents (DES) has not been well understood. We sought to determine
if the use of intravascular ultrasound during left main stenting with DES in high risk
patients yields future clinical benefit in terms of survival, and reduction in recurrent
myocardial infarction (MI) and revascularization.
Methods: Medical records of 624 patients who underwent left main coronary stenting
between August 1990 and November 2010 at Mayo Clinic were reviewed. 329 patients
who had implantation of bare metal stents were excluded. 111 patients who had
intravascular ultrasound performed during DES stenting of the left main were
compared with 184 patients with conventional angiography and stenting. Of the 295
patients with implantation of DES into the left main, 100 had unprotected left main
disease. Information was collected on patient characteristics, comorbidities,
presentation, ejection fraction, recurrent MI, target lesion and target vessel
revascularization and mortality. The primary end point was mortality. Secondary end
points were revascularization and MI.
Results: The two groups were well matched for clinical and angiographic
characteristics. Patients undergoing IVUS during DES implantation were less likely
to have had coronary artery bypass surgery, underwent more direct stenting, post-
dilatation, and had shorter stent length. At three years, there was no difference in
survival between the IVUS and NO IVUS group (15.8 vs.13.3%, p=0.833). There was
no difference in revascularization (17.7 vs. 20.6%, p=0.994) between the groups. There
was a trend towards increased MI in the IVUS compared to the NO IVUS group
although not statistically significant (11.5% vs 5.3%, p=0.073). Among the 100 patients
with unprotect left main and DES stenting; there were no difference in mortality,
revascularization and MI between the groups.
Conclusion: Utilization of intravascular ultrasound during implantation of DES into
the left main might not improve long-term mortality or reduce recurrent MI and
revascularization.
TCT-623
Intravascular Ultrasound and Optical Coherence Tomography Comparison of
the Self-expanding Sideguard Stent in the Sidebranch Versus a Balloon-
Expandable Drug-Eluting Stent in the Main Vessel: Follow-up Results of
Bifurcation Lesions Treated with this Novel Approach
Shixin Ma1, Akiko Maehara1, Karl E Hauptmann2, Giulio Guagliumi3, Orazio
Valsecchi3, Angelina Vassileva3, Yolande Appelman4, Giuseppe Sangiorgi5,
Francesco Prati6, Gary S Mintz1
1Cardiovascular Research Foundation, New York, NY; 2Bruderkrankenhaus, TRIER,
Germany; 3Ospedali Riuniti di Bergamo, DI BERGAMO, Italy; 4VU Medical Centre,
AMSTERDAM, Netherlands; 5University Hospital, MODENA, Italy; 6San Giovanni
Hospital, ROME, Italy
Background: The Cappella Sideguard sidebranch (SB) stent is a self-expanding, thin-
strut, nitinol device with anatomic flaring at the SB ostium.
Methods: We performed intravascular ultrasound (IVUS) post-intervention and IVUS
(n=28) and OCT (n=12) at follow-up and compared serial changes between the
Cappella Sideguard stent in the SB and a balloon-expandable drug-eluting stent (DES)
in the corresponding main vessel (MV).
Results: 1. Cappella Sideguard stent carinal area increased from 3.9±1.3mm2 post-
intervention to 4.6±1.3mm2 at follow-up (p<0.001) that led no change in lumen area
(3.9±1.3 to 3.8±1.2mm2, p=0.7) despite a neointimal hyperplasia (NIH) area of
0.8±0.8mm2. 2. Compared to the MV, in the SB there was a larger NIH volume and a
significant increase in stent (4.9±3.6 vs 0.3±3.0mm3, p<0.001) and vessel volumes,
with no difference in Δlumen volume. 3. NIH peaked 1-2mm distal to the carina
(Figure). 4. Using OCTNIH thickness at the SB side of the bifurcation was greater
than at the MV side, the percentage of uncovered struts was less (2.9% at SB vs 12.7%
at MV, p<0.001), and 61% of floating stent struts at the carina were covered by smooth
tissue.
Conclusion: The self-expanding Cappella Sideguard stent maintains an adequate
lumen, especially at the SB carina at follow-up, with NIH accumulation mainly 1~2mm
distal to the carina that correlates to the increase in stent dimensions.
TCT-624
Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting
Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in
One Procedure. A 12 Months Follow Up Evaluation
Jose M De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad
Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco
Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain
Background: Optical frequency-domain imaging (OFDI) allows a detailed assessment
of intimal coverage and strut apposition which are factors well known associated with
late thrombosis. This study seeks to asses and compare long term intimal coverage and
stent apposition with paclitaxel-eluting stents (PES) Taxus Liberte TM and everolimus-
eluting stents (EES) Xience Prime TM.
Methods: We have applied a particular clinical model, that of a same patient with two
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different de novo lesions in the same vessel within a distance enough to allow the
deployment of two non-overlapped stents and with similar morphological features.
Each lesion was treated with each drug-eluting stent in a randomized location. Patients
were evaluated at 12 months with an OFDI system. Off-line analysis of the continuous
cross-sections within the stented segment was performed at 1 mm intervals. The strut
apposition and neointimal coverage were assessed for each strut.
Results: A total of 30 patients were included (age 69±7 yrs, 33% diabetics, 60%
unstable angina, 40% stable angina). At 12 months 30 PES (length 18.1±8 mm and
diameter 2.57±0,3 mm) were examined analyzing 154±90 struts and 30 EES (length
16.4±5 mm and diameter 2.65±0,3 mm) analyzing 158±72 struts. The proportion of
non-covered struts was 1.5±2.9 % in PES and 0.8±1.3% in EES (p=0.2). The rate of
malapposition among non-covered struts was 58% in PES and 22.5% in EES
(p=0.0017) being the maximal malapposition area significantly larger with PES (0.6±
0.3 vs. 0.25± 0.2 mm2, p=0.001).
Conclusion: In very similar conditions, same patient, same artery and similar lesions
EES show a trend towards a greater degree of intimal coverage at one year follow up
compared to PES and a significant lower rate of malapposed non covered struts. These
findings suggest that very late thrombosis rate could be lower with EES as opposed to
PES.
TCT-625
Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap
segments in drug-eluting stents 9-13 months after implantation: in vivo-
assessment with optical coherence tomography
Juan Luis Gutiérrez-Chico1, Lorenz Räber2, Evelyn Regar1, Takayuki Okamura1,
Carlo di Mario3, Stephan Windecker2, Gerrit-Anne van Es4, Patrick W Serruys1
1Erasmus Medical Center - Thoraxcenter, Rotterdam, Netherlands; 2Swiss Heart
Center, Inselspital, Bern, Switzerland; 3Cardiovascular Biomedical Research Unit,
Royal Brompton and Harefield NHS Trust, London, United Kingdom; 4Cardialysis
BV, Rotterdam, Netherlands
Background: Although histologic experimental studies have reported delayed
neointimal healing in overlap compared to non-overlap segments in drug-eluting stents
(DES), these observations have not been confirmed in human coronary arteries hitherto.
On the contrary, angiographic and optical coherence tomography (OCT) studies suggest
that DES overlap elicits rather an exaggerated than an incomplete neointimal reaction.
We compare the coverage of overlap vs. non-overlap segments of the same lesion in
DES using OCT and accounting for eventual heterogeneity of the effect.
Methods: OCT studies from 2 randomized trials (NCT00617084, NCT00389220)
comparing different drug-eluting stents were analyzed at 9-13 months follow-up.
Coverage of struts in overlapping segments was compared vs. the corresponding non-
overlapping segments of the same stents, using statistical pooled analysis.
Results: 178 stents implanted in 99 patients were finally analyzed: 38 sirolimus-eluting
(SES), 33 biolimus-eluting (BES), 57 everolimus-eluting (EES) and 50 zotarolimus-
eluting stents (ZES); 34120 struts. The risk-ratio for non-coverage was 2.35 (95% CI:
1.86 – 2.98) in overlapping vs. non-overlapping segments. Thickness of coverage in
overlaps was only 85% (95% CI: 81 – 90%) of the thickness in non-overlaps.
Significant heterogeneity of the effect was observed, especially pronounced in the
comparison of thickness of coverage (I2=90.31).
Conclusion: DES struts in overlapping segments are at higher risk of incomplete tissue
coverage and are covered by a thinner neointimal layer than the struts in the
corresponding non-overlapping distal and proximal segments of the same stents at 9-
13 months. Although an average greater neointimal inhibition is observed in overlaps,
the neointimal reaction is subjected to pronounced interindividual variations.
TCT-626
Relation Inflammatory Status and Cholesterol Metabolism to Coronary Plaque
Vulnerability
Kenya Nasu, Mitsuyasu Terashima, Etsuo Tsuchikane, Maoto Habara, Osamu
Katoh, Takahiko Suzuki
Toyohashi Heart Center, Toyohashi, Japan
Background: The aim of this study is to evaluate the impact of inflammatory status
and surrogate marker levels of cholesterol metabolism on plaque vulnerability.
Methods: This study designed to enroll 80 stable angina pectoris patients. Non-culprit
vessels with more than 25% diameter stenosis by visual estimation were imaged with
a 20 MHz phased-array intravascular ultrasound (VH-IVUS) catheter (motorized pull-
back system at 0.5 mm/s) and optical coherence tomography (OCT) wire (motorized
pull-back system at 1 mm/s and analyzed at 0.3mm interval). Definite-fibroatheroma
(D-FA) was defined as 1) percent necrotic core area >20% in contact with the lumen
in VH-IVUS; 2) percent plaque plus media cross-sectional area >40% in VH-IVUS;
3) fibrous cap thickness at the thinnest part <65μm in OCT.
Results: High-sensitivity C-reaction protein (hsCRP), low-density lipoprotein (LDL)
cholesterol, campesterol, and the ratio of campesterol to lathosterol were significantly
positive correlation with percent necrotic core volume (%NCV). On the other hand,
lathosterol was significantly negative correlation with %NCV (table). In subgroup
divided by the incidence of D-FA, hsCRP, campesterol, and the ratio of campesterol
to lathosterol were significantly lower in no D-FA group (515±270 vs.967±457 ng/ml;
p=0.004, 159.2±83.3 vs. 218.5±92.4 μg/100mg total cholestenol; p=0.01, 1.82±1.01
vs. 3.50±1.50; p<0.0001), however lathosterol was significantly higher (96.1±44.2 vs.
68.5±29.3 μg/100mg total cholestenol; p=0.007).
Correlation cholesterol synthesis and absorption with percent necrotic core
volume
Conclusion: Higher inflammatory status, enhanced absorption, and reduced synthesis
of cholesterol may be related to plaque vulnerability.
TCT-627
Risk Evaluation of Distal Embolization During Percutaneous Coronary
Intervention by Angioscopy and Virtual Histology Intravascular Ultrasound
Imaging
Koshi Matsuo, Yasunori Ueda, Akio Hirata, Yasuhiro Akazawa, Kazuhisa Kodama
Osaka Police Hospital, Osaka, Japan
Background: Slow flow or no re-flow phenomenon is mainly induced by distal
embolization during PCI and is associated with unfavorable long-term clinical
outcomes. Various imaging modalities have failed to detect high risk patients of distal
embolization for whom distal protection might be beneficial. The object of this study
is to examine the frequency of distal embolization using filter-type distal protection
device and to clarify the predicting factors of distal embolization.
Methods: Consecutive patients (n=98) with or without ACS who received PCI with
filter-type distal protection device (Filtrap) and successful angioscopic and VH-IVUS
examination of target lesion were prospectively enrolled. Presence of yellow plaque
and plaque rupture were evaluated by angioscopy; and tissue classification and plaque
burden were evaluated by VH-IVUS. Distal embolization was evaluated by the
pathological examination of collected material in the filter device.
Results: Distal embolizatioin of thrombus tended to be frequent in ACS than in non
ACS patients (81.03% vs. 65%, P=0.074). That of plaque debris was more frequent in
ACS than non-ACS patients (48.28% vs. 25%, P<0.05). Distal embolization of plaque
debris was more frequent in the patients with rupured plaque than in those without it
(85.7% vs. 12.3%, p<0.05), in the patients with yellow plaque than in those without it
(50.7% vs. 7.0%, P<0.05), and tended to be more frequent in the patients with large
(>75%) plaque burden than in those without it (46.3% vs. 29.5%, p=0.09). Remarkably,
94% of patients with ruptured plaque and large plaque burden had distal embolization
of plaque debris.
Conclusion: Distal embolization of plaque debris was detected frequently in the
patients with ruptured yellow plaque and large plaque burden. Using both anigoscopy
and VH-IVUS before procedure, we may predict distal embolization. Filter-type distal
protection device would be potentially beneficial for those high risk patients.
TCT-628
Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent
Implantation: A Dosimetric 3D-Intravascular Ultrasound Study
Hideki Kitahara1, Teruyoshi Kume1, Katsuhisa Waseda1, Kenji Sakamoto1, Ryotaro
Yamada1, Paul Yock1, Ian T Meredith2, Martin B Leon3, Laura Mauri4, Alan C
Yeung1, Peter J Fitzgerald1, Yasuhiro Honda1
1Stanford University, Stanford, CA; 2Monash Heart and Medical Centre, Clayton,
Australia; 3Columbia University Medical Center/New York Presbyterian Hospital,
New York, NY; 4Harvard Medical School, Boston, MA
Background: In drug-eluting stents, a fixed loading dose per metal area may result in
considerable variability in actual dose exposed to vessel wall due to differences in strut
spacing once expanded in varying sizes of lesions. This study aimed to evaluate
potential effects of different dose intensity, as estimated by 3D-IVUS dosimetry, on
vascular response after Resolute zotarolimus-eluting stent (ZES) implantation.
Methods: Serial (baseline and 8-9 mo) 3D-IVUS was performed in 121 lesions treated
with a single Resolute ZES. Neointimal obstruction was calculated as neointima/stent
volume. Cross sectional narrowing (CSN) was defined as neointima/stent area. In each
lesion, exposed dose intensity was calculated as known loading dose/measured stented
segment surface area at post-procedure. Lesions were divided into tertiles based on the
dose intensity.
Results: The exposed dose intensity ranged from 0.76 to 1.58 μg/mm2 (1.08±0.18
μg/mm2). The low dose group showed a trend toward slightly greater neointima.
However, neointimal obstruction, max CSN, neointimal thickness, vessel remodeling,
and the incidence of late incomplete stent apposition were not significantly different
among the 3 groups.
Conclusion: Detailed 3D-IVUS dosimetry revealed a significant lesion-to-lesion
variability in dose intensity exposed to vessel wall following Resolute ZES
implantation. However, Resolute appears to yield equally effective neointimal
suppression and no evidence of adverse local vessel response, regardless of the varying
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